NASDAQ:ACON

Aclarion (ACON) News Today

$1.03

+0.04 (+4.48%)

(As of 05:40 PM ET)

Compare

Today's Range: $0.89
▼
$1.07
50-Day Range: $0.59
▼
$1.28
52-Week Range: $0.38
▼
$2.37

Volume: 326,242 shs
Average Volume: 1.23 million shs
Market Capitalization: $8.10 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

Get Aclarion News Delivered to You Automatically

ACON Media Mentions By Week

ACON Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACON
News Sentiment
▼
1.14

0.52
▲
Average
Medical
News Sentiment

ACON News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACON Articles
This Week
▼
2

1
▲
ACON Articles
Average Week

Source

Source	Headline
	Aclarion Announces New Engagement with The London Clinic and London Spine Clinic finance.yahoo.com - May 30 at 10:03 AM
	Aclarion, Inc. (NASDAQ:ACON) Sees Large Decline in Short Interest americanbankingnews.com - May 26 at 7:26 AM
	Aclarion, Inc. Announces Delayed 10-Q Filing finance.yahoo.com - May 23 at 9:54 AM
	Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD finance.yahoo.com - May 23 at 9:54 AM
	Critical Analysis: Vyant Bio (NASDAQ:VYNT) & Aclarion (NASDAQ:ACON) americanbankingnews.com - May 20 at 1:54 AM
	Aclarion gets $2M debt financing msn.com - May 19 at 9:31 AM
	Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts finance.yahoo.com - May 19 at 9:31 AM
	Aclarion (NASDAQ:ACON) and MedTech Acquisition (NASDAQ:MTAC) Head-To-Head Comparison americanbankingnews.com - May 18 at 2:56 AM
	Aclarion providing less invasive solution to treat lo back pain through augmented intelligence proactiveinvestors.com - May 10 at 1:42 PM
	Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023 finance.yahoo.com - April 28 at 4:34 PM
	Aclarion, Inc. (NASDAQ:ACON) Short Interest Up 95.6% in April americanbankingnews.com - April 28 at 5:22 AM
	Aclarion, Inc. (ACON) Interactive Stock Chart - Yahoo Finance ca.finance.yahoo.com - April 24 at 4:16 PM
	marketbeat.com - April 24 at 3:28 PM
	marketbeat.com - April 24 at 12:35 PM
	marketbeat.com - April 24 at 11:06 AM
	marketbeat.com - April 24 at 10:28 AM
	marketbeat.com - April 24 at 10:22 AM
	marketbeat.com - April 24 at 10:11 AM
	marketbeat.com - April 24 at 10:05 AM
	marketbeat.com - April 24 at 9:52 AM
	marketbeat.com - April 24 at 9:46 AM
	marketbeat.com - April 24 at 9:40 AM
	Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial finance.yahoo.com - April 24 at 9:25 AM
	Why Aclarion Shares Are Soaring Today benzinga.com - April 24 at 9:25 AM
	Aclarion Surges on Promising Nociscan Data in DLBP msn.com - April 24 at 9:25 AM
	Aclarion, Inc. (NASDAQ:ACON) Short Interest Update americanbankingnews.com - April 17 at 5:14 AM
	Head-To-Head Review: Castle Biosciences (NASDAQ:CSTL) vs. Aclarion (NASDAQ:ACON) americanbankingnews.com - March 30 at 2:52 AM
	Contrasting Castle Biosciences (NASDAQ:CSTL) & Aclarion (NASDAQ:ACON) americanbankingnews.com - March 30 at 2:52 AM
	Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor finance.yahoo.com - March 7 at 7:01 PM
	Aclarion to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th, 2023 finance.yahoo.com - February 16 at 8:02 AM
	Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium finance.yahoo.com - February 15 at 9:55 AM
	Insiders who bought stock earlier this year lose -US$213k as Aclarion, Inc. (NASDAQ:ACON) drops to US$4.7m finance.yahoo.com - February 5 at 11:19 AM
	Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor finance.yahoo.com - January 31 at 2:03 PM
	The Investor Summit: Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Event finanznachrichten.de - January 17 at 11:21 AM
	Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Event finance.yahoo.com - January 17 at 11:21 AM
	Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor finance.yahoo.com - January 17 at 11:21 AM
	Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor finance.yahoo.com - December 22 at 12:24 PM
	Aclarion’s Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MD finance.yahoo.com - December 21 at 2:58 PM
	Aclarion Adds to Growing Key Opinion Leader Program with Juan Uribe M.D. as a Surgeon Advisor finance.yahoo.com - December 19 at 9:46 AM
	Aclarion Adds to Strong Patent Portfolio with Notice of Allowance for New U.S. Patent Application Addressing Key Pain Indicator Biomarker finance.yahoo.com - December 1 at 4:02 PM
	ACON.OQ - Aclarion Inc \| Stock Price & Latest News \| Reuters reuters.com - November 30 at 3:53 PM
	Aclarion Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags finance.yahoo.com - November 16 at 5:38 AM
	Aclarion, Inc. Releases Updated Investor Presentation In Connection with Appearance at LD Micro Main Event XV finance.yahoo.com - October 25 at 10:38 AM
	Dr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisor finance.yahoo.com - October 24 at 9:12 AM
	Aclarion To Present at The LD Micro Main Event XV finance.yahoo.com - October 12 at 11:10 AM
	Aclarion Inc.: Aclarion Announces Participation at the NASS 37th Annual Meeting finanznachrichten.de - October 10 at 8:02 AM
	Aclarion Announces Participation at the NASS 37th Annual Meeting finance.yahoo.com - October 10 at 8:02 AM
	Aclarion Inc.: John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor finanznachrichten.de - October 5 at 12:55 PM
	John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor finance.yahoo.com - October 3 at 9:10 AM
	Aclarion Inc.: Nociscan Selected for Inclusion in Pivotal National Institutes of Health Study for Low Back Pain finanznachrichten.de - September 20 at 7:09 PM

Get Aclarion News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ACON) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Aclarion (ACON) News Today

ACON Media Mentions By Week

ACON Media Sentiment

ACON News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info